Spotlight on Buprenorphine/Naloxone in the Treatment of Opioid Dependence†

By Orman Jennifer S.   Keating Gillian M.  

CNS Drugs, Vol. 23, Iss. 10, 2009-10 ,pp. : 899-902

Adis International

Access to resources Recommend Favorite

Evaluation of Buprenorphine Dosage Adequacy in Opioid Receptor Agonist Substitution Therapy for Heroin Dependence: First Use of the Buprenorphine-Naloxone Dosage Adequacy Evaluation (BUDAVA) Questionnaire

By D'Amore Antonio  

Clinical Drug Investigation, Vol. 32, Iss. 7, 2012-07 ,pp. : 427-432

Adis International

Access to resources Recommend Favorite

Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review

By  

Current Drug Abuse Reviews, Vol. 4, Iss. 1, 2011-03 ,pp. : 28-41

Bentham Science Publishers

Access to resources Recommend Favorite

Behavioral Counseling Content for Optimizing the Use of Buprenorphine for Treatment of Opioid Dependence in Community-Based Settings: A Review of the Empirical Evidence

By Copenhaver Michael   Bruce R. Douglas   Altice Frederick  

The American Journal of Drug and Alcohol Abuse, Vol. 33, Iss. 5, 2007-09 ,pp. : 643-654

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic Interactions between Buprenorphine/Naloxone and Raltegravir in Subjects Receiving Chronic Buprenorphine/Naloxone Treatment

By Douglas Bruce R.  

The American Journal of Drug and Alcohol Abuse, Vol. 39, Iss. 2, 2013-03 ,pp. : 80-85

Informa Healthcare

Access to resources Recommend Favorite